1. What data in particular will be shared?
   Response - All of the individual participant data collected during the trial, after de-identification.
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Clinical Study Report
   
   
3. Who will be able to view these files?
   Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
   


4. For what types of analyses will this data be available?
   Response - Any purpose.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [leninsurendran161@gmail.com].
   


6. For how long will this data be available start date provided 26-06-2025 and end date provided 11-11-2027?
   Response - Immediately following publication. No end date.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - nil

This quasi-experimental clinical study evaluates the effectiveness of individualized homoeopathic medicine in reducing the callous unemotional traits in conduct disorder using the inventory callous unemotional Scale (ICU). Secondary objectives include assessing overall improvement in conduct disorder through the Conduct disorder rating scale (CDRS) scale and clinical global improvement (CGI), determining whether homoeopathy helps reducing the callous unemotional traits in conduct disorder. Patients will be recruited from the Outpatient Department (OPD), Inpatient Department (IPD), and Peripheral Centre of the National Homoeopathic Research Institute in Mental Health (NHRIMH), Kottayam, following screening based on DSM 5 criteria. Enrolment requires psychiatric confirmation, and informed consent will be obtained in English and Malayalam. Baseline assessments include ICU for Callous unemotional traits and CDRS for conduct disorder, with evaluations conducted monthly and trio-monthly, respectively, . A detailed case history and mental status examination will be recorded, and individualized homoeopathic remedies will be prescribed based on repertorization via RADAR OPUS software and Homoeopathic Materia Medica. Acute exacerbations will be managed accordingly.  Patients missing follow-ups for three consecutive months will be considered dropouts and will receive standard OPD care but will be excluded from further study evaluation. The study aims to provide clinical evidence on homoeopathy’s role as an reducing the callous unemotional traits in conduct disorder assessing its ability to improve symptoms, enhance quality of life and avoids antisocial personality in future of the affected individuals.